Position Statements for the Diagnosis and Treatment of Pulmonary Fibrosis
Diagnosis and of pulmonary fibrosis is extremely challenging as it requires integration of clinical, radiologic and histopathologic information.
Treatment of pulmonary fibrosis is also difficult as there is no cure for many types, but there are various treatment options and management strategies to stop or slow the progression of the condition and manage symptoms.
We have developed position statements for the diagnosis and management of pulmonary fibrosis in Australia in partnership with the Thoracic Society of Australia and New Zealand and Lung Foundation Australia.
- Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand
- Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
- Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia
- The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia
- Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand